Highlights and Quick Summary
- Revenue for the quarter ending February 28, 2023 was $29.3 Million (a -8.98% decrease compared to previous quarter)
- Year-over-year quarterly Revenue decreased by -2.44%
- Annual Revenue for 2022 was $115 Million (a 83.6% increase from previous year)
- Annual Revenue for 2021 was $62.4 Million (a -3.3% decrease from previous year)
- Annual Revenue for 2020 was $64.6 Million (a 6.45% increase from previous year)
- Twelve month Revenue ending February 28, 2023 was $127 Million (a 3.45% increase compared to previous quarter)
- Twelve month trailing Revenue increased by 27.76% year-over-year
Trailing Revenue for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| $127 Million | $123 Million | $115 Million | $99.3 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Revenue of Organigram Holdings Inc.
Most recent Revenueof OGI including historical data for past 10 years.Interactive Chart of Revenue of Organigram Holdings Inc.
Organigram Holdings Inc. Revenue for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $29.26 | – | – | – | – |
| 2022 | $32.15 | $35.42 | $30.0 | $25.04 | $114.64 |
| 2021 | $24.18 | $20.05 | $16.21 | $11.49 | $62.44 |
| 2020 | $14.68 | $15.02 | $12.9 | $17.63 | $64.57 |
| 2019 | $19.03 | $12.47 | $18.46 | $20.21 | $60.66 |
| 2018 | – | – | $9.51 | $2.52 | $9.73 |
| 2017 | – | – | – | – | $4.24 |
| 2016 | – | – | – | – | $4.68 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic